Evidence map›Paper›PMID 34286362›Full record

ReviewInflammation research : official journal of the European Histamine Research Society ... [et al.]2021

SARS-CoV-2 and pathological matrix remodeling mediators.

Imen Guizani, Nesrine Fourti, Wiem Zidi, Moncef Feki, Monia Allal-Elasmi

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05844215 (Role of MMP-9, TIMP-1 as Markers of Lung Imaging and Functional Abnormality of COVID-19), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05844215 completednot on this map

Role of MMP-9, TIMP-1 as Markers of Lung Imaging and Functional Abnormality of COVID-19

Typeobservational_patient_registrySponsorUniversitas AirlanggaRan2021 to 2022Enrolled78ConditionsPulmonary Infection, COVID-19, Extracellular Matrix AlterationArmsMMP-9 and TIMP-1
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Advances in Biomarkers for Diagnosis and Treatment of ARDS.Diagnostics (Basel, Switzerland) · 2023
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Imen GuizaniLR99ES11, Laboratory of Biochemistry, Department of Biochemistry, Faculty of Medicine, La Rabta Hospital, University of Tunis El Manar, Jebbari, 1007, Tunis, Tunisia.
Nesrine FourtiLR99ES11, Laboratory of Biochemistry, Department of Biochemistry, Faculty of Medicine, La Rabta Hospital, University of Tunis El Manar, Jebbari, 1007, Tunis, Tunisia.
Wiem ZidiLR99ES11, Laboratory of Biochemistry, Department of Biochemistry, Faculty of Medicine, La Rabta Hospital, University of Tunis El Manar, Jebbari, 1007, Tunis, Tunisia.
Moncef FekiLR99ES11, Laboratory of Biochemistry, Department of Biochemistry, Faculty of Medicine, La Rabta Hospital, University of Tunis El Manar, Jebbari, 1007, Tunis, Tunisia.
Monia Allal-ElasmiLR99ES11, Laboratory of Biochemistry, Department of Biochemistry, Faculty of Medicine, La Rabta Hospital, University of Tunis El Manar, Jebbari, 1007, Tunis, Tunisia. monia_elasmi@yahoo.fr.ORCID http://orcid.org/0000-0002-5325-6347
Tunis El Manar University · TNTunis University · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecognizing only sharp elevation in a short period of time, the COVID-19 SARS-CoV-2 propagation is more and more marked in the whole world. Induced inflammation afterwards infection engenders a high infiltration of immune cells and cytokines that triggers matrix metalloproteinases (MMPs) activation. These endopeptidases are mediators of the lung extracellular matrix (ECM), a basic element for alveoli structure and gas exchange.

methodsWhen immune cells, MMPs, secreted cytokines and several other mediators are gathered a pathological matrix remodeling occurs. This phenomenon tends to tissue destruction in the first place and a pulmonary hypertrophy and fibrosis in the second place.

findingsAfter pathological matrix remodeling establishment, pathological diseases take place even after infection state. Since post COVID-19 pulmonary fibrosis is an emerging complication of the disease, there is an urge to better understand and characterize the implication of ECM remodeling during SARS-CoV-2 infection.

conclusionTargeting MMPs and their inhibitors could be a probable solution for occurred events since there are many cured patients that remain with severe sequels even after the end of infection.

Indexed as

SARS-CoV-2Cell CommunicationCell LineageCOVID-19CytokinesCytoplasmExtracellular MatrixFibrosisHomeostasisHumansHypertrophyImmune SystemInterferon-gammaLungMatrix MetalloproteinasesPulmonary AlveoliCytokinesInterferon-gammaMatrix MetalloproteinasesCytokineImmune cellsMatrix remodelingMMPsSARS-CoV-2Therapeutic target

Identifiers

PMID34286362
PMCPMC8294315
OpenAlexW3183171158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.